Rare copy number variants in neuropsychiatric disorders: specific phenotype or not?

Maarten J Van Den Bossche, Mandy Johnstone, Mojca Strazisar, Benjamin S Pickard, Dirk Goossens, An-Sofie Lenaerts, Sonia De Zutter, Annelie Nordin, Karl-Fredrik Norrback, Julien Mendlewicz, Daniel Souery, Peter De Rijk, Bernard G Sabbe, Rolf Adolfsson, Douglas Blackwood, Jurgen Del-Favero

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

From a number of genome-wide association studies it was shown that de novo and/or rare copy number variants (CNVs) are found at an increased frequency in neuropsychiatric diseases. In this study we examined the prevalence of CNVs in six genomic regions (1q21.1, 2p16.3, 3q29, 15q11.2, 15q13.3, and 16p11.2) previously implicated in neuropsychiatric diseases. Hereto, a cohort of four neuropsychiatric disorders (schizophrenia, bipolar disorder, major depressive disorder, and intellectual disability) and control individuals from three different populations was used in combination with Multilpex Amplicon Quantifiaction (MAQ) assays, capable of high resolution (kb range) and custom-tailored CNV detection. Our results confirm the etiological candidacy of the six selected CNV regions for neuropsychiatric diseases. It is possible that CNVs in these regions can result in disturbed brain development and in this way lead to an increased susceptibility for different neuropsychiatric disorders, dependent on additional genetic and environmental factors. Our results also suggest that the neurodevelopmental component is larger in the etiology of schizophrenia and intellectual disability than in mood disorders. Finally, our data suggest that deletions are in general more pathogenic than duplications. Given the high frequency of the examined CNVs (1-2%) in patients of different neuropsychiatric disorders, screening of large cohorts with an affordable and feasible method like the MAQ assays used in this study is likely to result in important progress in unraveling the genetic factors leading to an increased susceptibility for several psychiatric disorders. © 2012 Wiley Periodicals, Inc.
LanguageEnglish
Number of pages11
JournalAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Early online date22 Aug 2012
DOIs
Publication statusPublished - 2012

Fingerprint

Phenotype
Intellectual Disability
Schizophrenia
Genome-Wide Association Study
Major Depressive Disorder
Mood Disorders
Bipolar Disorder
Psychiatry
Cross-Sectional Studies
Brain
Population

Keywords

  • rare
  • copy number variants
  • neuropsychiatric disorders
  • specific phenotype
  • schizophrenia
  • intellectual disability
  • major depressive disorder
  • bipolar disorder

Cite this

Van Den Bossche, Maarten J ; Johnstone, Mandy ; Strazisar, Mojca ; Pickard, Benjamin S ; Goossens, Dirk ; Lenaerts, An-Sofie ; De Zutter, Sonia ; Nordin, Annelie ; Norrback, Karl-Fredrik ; Mendlewicz, Julien ; Souery, Daniel ; De Rijk, Peter ; Sabbe, Bernard G ; Adolfsson, Rolf ; Blackwood, Douglas ; Del-Favero, Jurgen. / Rare copy number variants in neuropsychiatric disorders : specific phenotype or not?. In: American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2012.
@article{a4fa3007d3bb483e9c5302fef2ee557b,
title = "Rare copy number variants in neuropsychiatric disorders: specific phenotype or not?",
abstract = "From a number of genome-wide association studies it was shown that de novo and/or rare copy number variants (CNVs) are found at an increased frequency in neuropsychiatric diseases. In this study we examined the prevalence of CNVs in six genomic regions (1q21.1, 2p16.3, 3q29, 15q11.2, 15q13.3, and 16p11.2) previously implicated in neuropsychiatric diseases. Hereto, a cohort of four neuropsychiatric disorders (schizophrenia, bipolar disorder, major depressive disorder, and intellectual disability) and control individuals from three different populations was used in combination with Multilpex Amplicon Quantifiaction (MAQ) assays, capable of high resolution (kb range) and custom-tailored CNV detection. Our results confirm the etiological candidacy of the six selected CNV regions for neuropsychiatric diseases. It is possible that CNVs in these regions can result in disturbed brain development and in this way lead to an increased susceptibility for different neuropsychiatric disorders, dependent on additional genetic and environmental factors. Our results also suggest that the neurodevelopmental component is larger in the etiology of schizophrenia and intellectual disability than in mood disorders. Finally, our data suggest that deletions are in general more pathogenic than duplications. Given the high frequency of the examined CNVs (1-2{\%}) in patients of different neuropsychiatric disorders, screening of large cohorts with an affordable and feasible method like the MAQ assays used in this study is likely to result in important progress in unraveling the genetic factors leading to an increased susceptibility for several psychiatric disorders. {\circledC} 2012 Wiley Periodicals, Inc.",
keywords = "rare , copy number variants , neuropsychiatric disorders, specific phenotype, schizophrenia, intellectual disability, major depressive disorder, bipolar disorder",
author = "{Van Den Bossche}, {Maarten J} and Mandy Johnstone and Mojca Strazisar and Pickard, {Benjamin S} and Dirk Goossens and An-Sofie Lenaerts and {De Zutter}, Sonia and Annelie Nordin and Karl-Fredrik Norrback and Julien Mendlewicz and Daniel Souery and {De Rijk}, Peter and Sabbe, {Bernard G} and Rolf Adolfsson and Douglas Blackwood and Jurgen Del-Favero",
note = "Copyright {\circledC} 2012 Wiley Periodicals, Inc.",
year = "2012",
doi = "10.1002/ajmg.b.32088",
language = "English",
journal = "American Journal of Medical Genetics. Part B : Neuropsychiatric Genetics",
issn = "1552-4841",

}

Van Den Bossche, MJ, Johnstone, M, Strazisar, M, Pickard, BS, Goossens, D, Lenaerts, A-S, De Zutter, S, Nordin, A, Norrback, K-F, Mendlewicz, J, Souery, D, De Rijk, P, Sabbe, BG, Adolfsson, R, Blackwood, D & Del-Favero, J 2012, 'Rare copy number variants in neuropsychiatric disorders: specific phenotype or not?' American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.32088

Rare copy number variants in neuropsychiatric disorders : specific phenotype or not? / Van Den Bossche, Maarten J; Johnstone, Mandy; Strazisar, Mojca; Pickard, Benjamin S; Goossens, Dirk; Lenaerts, An-Sofie; De Zutter, Sonia; Nordin, Annelie; Norrback, Karl-Fredrik; Mendlewicz, Julien; Souery, Daniel; De Rijk, Peter; Sabbe, Bernard G; Adolfsson, Rolf; Blackwood, Douglas; Del-Favero, Jurgen.

In: American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Rare copy number variants in neuropsychiatric disorders

T2 - American Journal of Medical Genetics. Part B : Neuropsychiatric Genetics

AU - Van Den Bossche, Maarten J

AU - Johnstone, Mandy

AU - Strazisar, Mojca

AU - Pickard, Benjamin S

AU - Goossens, Dirk

AU - Lenaerts, An-Sofie

AU - De Zutter, Sonia

AU - Nordin, Annelie

AU - Norrback, Karl-Fredrik

AU - Mendlewicz, Julien

AU - Souery, Daniel

AU - De Rijk, Peter

AU - Sabbe, Bernard G

AU - Adolfsson, Rolf

AU - Blackwood, Douglas

AU - Del-Favero, Jurgen

N1 - Copyright © 2012 Wiley Periodicals, Inc.

PY - 2012

Y1 - 2012

N2 - From a number of genome-wide association studies it was shown that de novo and/or rare copy number variants (CNVs) are found at an increased frequency in neuropsychiatric diseases. In this study we examined the prevalence of CNVs in six genomic regions (1q21.1, 2p16.3, 3q29, 15q11.2, 15q13.3, and 16p11.2) previously implicated in neuropsychiatric diseases. Hereto, a cohort of four neuropsychiatric disorders (schizophrenia, bipolar disorder, major depressive disorder, and intellectual disability) and control individuals from three different populations was used in combination with Multilpex Amplicon Quantifiaction (MAQ) assays, capable of high resolution (kb range) and custom-tailored CNV detection. Our results confirm the etiological candidacy of the six selected CNV regions for neuropsychiatric diseases. It is possible that CNVs in these regions can result in disturbed brain development and in this way lead to an increased susceptibility for different neuropsychiatric disorders, dependent on additional genetic and environmental factors. Our results also suggest that the neurodevelopmental component is larger in the etiology of schizophrenia and intellectual disability than in mood disorders. Finally, our data suggest that deletions are in general more pathogenic than duplications. Given the high frequency of the examined CNVs (1-2%) in patients of different neuropsychiatric disorders, screening of large cohorts with an affordable and feasible method like the MAQ assays used in this study is likely to result in important progress in unraveling the genetic factors leading to an increased susceptibility for several psychiatric disorders. © 2012 Wiley Periodicals, Inc.

AB - From a number of genome-wide association studies it was shown that de novo and/or rare copy number variants (CNVs) are found at an increased frequency in neuropsychiatric diseases. In this study we examined the prevalence of CNVs in six genomic regions (1q21.1, 2p16.3, 3q29, 15q11.2, 15q13.3, and 16p11.2) previously implicated in neuropsychiatric diseases. Hereto, a cohort of four neuropsychiatric disorders (schizophrenia, bipolar disorder, major depressive disorder, and intellectual disability) and control individuals from three different populations was used in combination with Multilpex Amplicon Quantifiaction (MAQ) assays, capable of high resolution (kb range) and custom-tailored CNV detection. Our results confirm the etiological candidacy of the six selected CNV regions for neuropsychiatric diseases. It is possible that CNVs in these regions can result in disturbed brain development and in this way lead to an increased susceptibility for different neuropsychiatric disorders, dependent on additional genetic and environmental factors. Our results also suggest that the neurodevelopmental component is larger in the etiology of schizophrenia and intellectual disability than in mood disorders. Finally, our data suggest that deletions are in general more pathogenic than duplications. Given the high frequency of the examined CNVs (1-2%) in patients of different neuropsychiatric disorders, screening of large cohorts with an affordable and feasible method like the MAQ assays used in this study is likely to result in important progress in unraveling the genetic factors leading to an increased susceptibility for several psychiatric disorders. © 2012 Wiley Periodicals, Inc.

KW - rare

KW - copy number variants

KW - neuropsychiatric disorders

KW - specific phenotype

KW - schizophrenia

KW - intellectual disability

KW - major depressive disorder

KW - bipolar disorder

UR - http://www.scopus.com/inward/record.url?scp=84866339204&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.32088

DO - 10.1002/ajmg.b.32088

M3 - Article

JO - American Journal of Medical Genetics. Part B : Neuropsychiatric Genetics

JF - American Journal of Medical Genetics. Part B : Neuropsychiatric Genetics

SN - 1552-4841

ER -